FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 141 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,516,000 | +2129.4% | 322,452 | +2805.0% | 0.08% | +1014.3% |
| Q2 2020 | $68,000 | -97.8% | 11,100 | -85.2% | 0.01% | -99.2% |
| Q3 2017 | $3,068,000 | +844.0% | 75,000 | +735.0% | 0.90% | +835.4% |
| Q1 2017 | $325,000 | -54.2% | 8,982 | -36.5% | 0.10% | -63.1% |
| Q4 2016 | $709,000 | -9.9% | 14,150 | -5.7% | 0.26% | +8.8% |
| Q3 2016 | $787,000 | +43.6% | 15,000 | +13.2% | 0.24% | +2.6% |
| Q2 2016 | $548,000 | +1.9% | 13,250 | 0.0% | 0.23% | -4.9% |
| Q1 2016 | $538,000 | -3.9% | 13,250 | -1.9% | 0.24% | +3.8% |
| Q4 2015 | $560,000 | – | 13,500 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|